Results 261 to 270 of about 260,635 (346)
Some of the next articles are maybe not open access.

Proton Magnetic Resonance Spectroscopy for Dementia

2017
Proton magnetic resonance spectroscopy (MRS) can be used to investigate metabolite changes and shows potential for clinical study and diagnosis of degenerative disorders such as mild cognitive impairment (MCI), Alzheimer’s disease (AD), dementia with Lewy bodies (DLB), and frontotemporal dementia (FTD).
A. Shiino
openaire   +2 more sources

Proton magnetic resonance spectroscopy

Critical Reviews in Neurosurgery, 1999
Proton magnetic resonance spectroscopy (MRS) permits in vivo determination of biochemical parameters within brain tissue, utilizing the same magnetic resonance (MR) scanner and head coil that are utilized for conventional MR imaging. This technology has been evolving and improving over the past decade, with most of the current published work based on ...
, Zimmerman, , Wang
openaire   +3 more sources

Deep learning‐based target metabolite isolation and big data‐driven measurement uncertainty estimation in proton magnetic resonance spectroscopy of the brain

Magnetic Resonance in Medicine, 2020
The aim of this study was to develop a method for metabolite quantification with simultaneous measurement uncertainty estimation in deep learning‐based proton magnetic resonance spectroscopy (1H‐MRS).
Hyeong Hun Lee, Hyeonjin Kim
semanticscholar   +1 more source

Intact metabolite spectrum mining by deep learning in proton magnetic resonance spectroscopy of the brain

Magnetic Resonance in Medicine, 2019
To develop a robust method for brain metabolite quantification in proton magnetic resonance spectroscopy (1H‐MRS) using a convolutional neural network (CNN) that maps in vivo brain spectra that are typically degraded by low SNR, line broadening, and ...
Hyeong Hun Lee, Hyeonjin Kim
semanticscholar   +1 more source

Glutamatergic Neurometabolite Levels in Patients With Ultra-Treatment-Resistant Schizophrenia: A Cross-Sectional 3T Proton Magnetic Resonance Spectroscopy Study.

Biological Psychiatry, 2019
BACKGROUND In terms of antipsychotic treatment response, patients with schizophrenia can be classified into three groups: 1) treatment resistant to both non-clozapine (non-CLZ) antipsychotics and CLZ (ultra-treatment-resistant schizophrenia [URS]), 2 ...
Y. Iwata   +12 more
semanticscholar   +1 more source

Proton magnetic resonance spectroscopy with dementia

Surgical Neurology, 1993
To provide new insights into metabolic changes in the brain of patients with dementia, we performed in vivo localized proton magnetic resonance spectroscopy in nine patients with primary degenerative dementia and in three patients with normal-pressure hydrocephalus. We compared the results with those in 26 healthy volunteers.
A, Shiino   +5 more
openaire   +2 more sources

Proton magnetic resonance spectroscopy in schizophrenia

European Journal of Radiology, 1999
Proton magnetic resonance spectroscopy (MRS) has become an important tool to study in vivo certain biochemical aspects of brain disorders. In the last decade this technique has been applied to the in vivo investigation of pathophysiological aspects of psychiatric disorders, extending knowledge of the related brain alterations. This review will focus on
BERTOLINO, Alessandro, DR WEINBERGER
openaire   +2 more sources

Proton magnetic resonance spectroscopy in the fetus

European Journal of Obstetrics & Gynecology and Reproductive Biology, 2011
Magnetic Resonance Imaging (MRI) has become an established technique in fetal medicine, providing complementary information to ultrasound in studies of the brain. MRI can provide detailed structural information irrespective of the position of the fetal head or maternal habitus.
Story, Lisa   +6 more
openaire   +3 more sources

Proton Magnetic Resonance Spectroscopy in Prostate Tuberculosis

Urology, 2010
Prostate tuberculosis is an uncommon disease of the prostate, which usually involves the upper urinary tract. In the elderly patients, it may be mistaken for prostate carcinoma, both clinically and by conventional radiology. However, magnetic resonance spectroscopy can provide more information to differentiate prostate tuberculosis from prostate cancer.
Yaqing, Chen, Mingjuan, Liu, Yan, Guo
openaire   +2 more sources

Proton magnetic resonance spectroscopy in primary blepharospasm

Neurology, 1998
Single-volume proton magnetic resonance spectroscopy, localized to basal ganglia, was carried out in 10 patients with primary blepharospasm (PB) to assess the levels of N-acetyl aspartate (NAA), creatine-phosphocreatine, and choline-containing compounds. NAA was reduced significantly in patients compared with control subjects.
Federico F   +8 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy